Your browser doesn't support javascript.
loading
Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.
Bain, William; Li, Huihua; van der Geest, Rick; Moore, Sara R; Olonisakin, Tolani F; Ahn, Brian; Papke, Erin; Moghbeli, Kaveh; DeSensi, Rebecca; Rapport, Sarah; Saul, Melissa; Hulver, Mei; Xiong, Zeyu; Mallampalli, Rama K; Ray, Prabir; Morris, Alison; Ma, Lina; Doi, Yohei; Zhang, Yingze; Kitsios, Georgios D; Kulkarni, Hrishikesh S; McVerry, Bryan J; Ferreira, Viviana P; Nouraie, Mehdi; Lee, Janet S.
Afiliação
  • Bain W; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Li H; Veterans Health Administration Pittsburgh Health System, Pittsburgh, Pennsylvania.
  • van der Geest R; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
  • Moore SR; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Olonisakin TF; Department of Medical Microbiology and Immunology, University of Toledo College of Life Sciences, Toledo, Ohio.
  • Ahn B; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Papke E; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Moghbeli K; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • DeSensi R; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Rapport S; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Saul M; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Hulver M; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Xiong Z; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Mallampalli RK; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Ray P; Department of Medicine, Ohio State University, Columbus, Ohio; and.
  • Morris A; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Ma L; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Doi Y; Center for Medicine and the Microbiome.
  • Zhang Y; Division of Pulmonary and Critical Care Medicine, Washington University, St. Louis, Missouri.
  • Kitsios GD; Division of Infectious Diseases, Department of Medicine, and.
  • Kulkarni HS; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • McVerry BJ; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
  • Ferreira VP; Center for Medicine and the Microbiome.
  • Nouraie M; Division of Pulmonary and Critical Care Medicine, Washington University, St. Louis, Missouri.
  • Lee JS; Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Am J Respir Crit Care Med ; 202(2): 230-240, 2020 07 15.
Article em En | MEDLINE | ID: mdl-32374177
Rationale: Complement is crucial for host defense but may also drive dysregulated inflammation. There is limited understanding of alternative complement function, which can amplify all complement activity, during critical illness.Objectives: We examined the function and key components of the alternative complement pathway in a series of critically ill patients and in a mouse pneumonia model.Methods: Total classical (CH50) and alternative complement (AH50) function were quantified in serum from 321 prospectively enrolled critically ill patients and compared with clinical outcomes. Alternative pathway (AP) regulatory factors were quantified by ELISA (n = 181) and examined via transcriptomics data from external cohorts. Wild-type, Cfb-/-, and C3-/- mice were infected intratracheally with Klebsiella pneumoniae (KP) and assessed for extrapulmonary dissemination.Measurements and Main Results: AH50 greater than or equal to median, but not CH50 greater than or equal to median, was associated with decreased 30-day mortality (adjusted odds ratio [OR], 0.53 [95% confidence interval (CI), 0.31-0.91]), independent of chronic liver disease. One-year survival was improved in patients with AH50 greater than or equal to median (adjusted hazard ratio = 0.59 [95% CI, 0.41-0.87]). Patients with elevated AH50 had increased levels of AP factors B, H, and properdin, and fewer showed a "hyperinflammatory" subphenotype (OR, 0.30 [95% CI, 0.18-0.49]). Increased expression of proximal AP genes was associated with improved survival in two external cohorts. AH50 greater than or equal to median was associated with fewer bloodstream infections (OR, 0.67 [95% CI, 0.45-0.98). Conversely, depletion of AP factors, or AH50 less than median, impaired in vitro serum control of KP that was restored by adding healthy serum. Cfb-/- mice demonstrated increased extrapulmonary dissemination and serum inflammatory markers after intratracheal KP infection compared with wild type.Conclusions: Elevated AP function is associated with improved survival during critical illness, possibly because of enhanced immune capacity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Análise de Sobrevida / Estado Terminal / Via Alternativa do Complemento Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Análise de Sobrevida / Estado Terminal / Via Alternativa do Complemento Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article